Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
20-hydroxyecdysone (2 trials)
Muscle Weakness (Phase 2)
Sarcopenia (Phase 2)
Trials (2 total)
Trial APIs (1 total)